Diagnostic experience
Selected patients receiving diagnostics cannot be used to estimate population prevalence. Interpretation requires a defined sample, setting, period, complete-data denominator and adjudication method.
Service volumes describe delivery experience. Study context and follow-up are needed to understand what diagnostic access changes for patients.
Source: Cumulative program activity in Ghana reported by HeartLINK+, through 30 August 2026. A patient may receive more than one diagnostic service; these totals are not unique patient counts or independently validated patient outcomes.
Population: people receiving assessment or diagnostics supported by HeartLINK+. Period: cumulative through 30 August 2026. Setting: Ghana implementation sites. Status: service delivery.
Figures are rounded activity totals, not a single study sample. Modalities may overlap for an individual patient. Current site availability is a separate question.
Selected patients receiving diagnostics cannot be used to estimate population prevalence. Interpretation requires a defined sample, setting, period, complete-data denominator and adjudication method.
Management change, newly recognized conditions and different clinical decisions require prospectively defined measures and clear methods.
Additional diagnostic and preliminary site-level analyses are awaiting finalized methods and denominators before numerical results are presented here.
| Area | Measures to track |
|---|---|
| Network reach | Active ACCESS sites and diagnostic hubs; patients entering the pathway. |
| Diagnostic delivery | Study volume, completeness, technical quality and repeat acquisition. |
| Expert interpretation | Report turnaround, critical findings and escalation acknowledgment. |
| Connection | Referral recommendations, completion and time to evaluation. |
| Closure and sustainability | Closed pathways, facility utilization and sustainable operating capacity. |
Explore diagnostic quality, clinical action and completion alongside service volume.